Finnish MedTech Startup Surgify Medical Secures €7M To Make Bone Surgery Safer

ZEISS Ventures, the investment arm of Carl Zeiss Group, led the funding round. The European Innovation Council Fund (EIC Fund) and Surgify’s current investors, Lednil and Cascara Ventures, also joined in.

“ZEISS brings unparalleled experience in surgical technology and a global network, while the EIC’s continued support and earlier grant financing underscore the European innovation ecosystem’s confidence in our solution,” said Visa Sippola, Co-founder and CEO of Surgify Medical. “With this funding and regulatory approvals in both the EU and the U.S., we are well-positioned to bring our unique technology to more surgeons and patients internationally.”

Surgify Halo isn’t just useful for head, neck, and spine surgeries—it could also play a big role in robotic surgery by making automated bone cutting more reliable.

Read Also - CurifyLabs Funding News – Finnish Healthtech Company CurifyLabs Secures €6.7M

With the new funding, Surgify aims to become a top player in the multi-billion-euro bone surgery market. After a successful launch in the Nordics, the company now plans to expand across the EU and the U.S., where some major hospitals have already started using their technology.

“Surgify’s technology is a major breakthrough in today’s evolving healthcare landscape. With over a thousand patient procedures, Surgify Halo has already left a significant footprint in the field. The company aims to protect patients, save costs, and has already achieved groundbreaking developments in robotic surgery applications,” said Alan Raffensperger, Chairman of Surgify Medical.

Conventional surgical drills rotate at extremely high speeds and can cause serious harm if they touch important soft tissues. This kind of damage can lead to severe injuries during surgery.

Soft tissue injuries are a major concern in head, neck, and spine surgeries involving bone cutting. These complications cost healthcare systems more than €4 billion each year around the world.

Surgify Halo is designed to cut bone while protecting soft tissues like nerves, blood vessels, and parts of the central nervous system.

It allows surgeons to remove bone safely and precisely, reducing the risk of accidental injuries during surgery.

“We are excited to partner with Surgify in their mission to establish a new benchmark for surgical safety. Surgify’s Halo burrs offer exceptional control at cutting rates comparable to traditional burrs, while simultaneously safeguarding delicate soft tissues. This makes the switch to Halo burrs an obvious choice for surgeons,” explains Dr Boris Hofmann, Head of ZEISS Ventures. “We are eager to support the team as they expand their solution on a global scale.”

So far, Surgify Medical has raised a total of €14 million. The company has offices in Finland, Sweden, Denmark, and the United States.

About Surgify Medical

Founded in 2017, Surgify Medical is focused on improving bone surgery. Their main product, Surgify Halo, helps surgeons tell the difference between hard and soft tissues. This makes surgery safer, reduces the risk of soft tissue damage, and helps procedures go more smoothly and quickly.